Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Frederick Welt Added: 2 weeks ago
Expand your understanding of acute coronary syndromes beyond traditional plaque rupture with Dr Frederick Welt.In this presentation, part of the Complex Cases track in Women As One's CLIMB® 2025 Skills Training Program, Dr Frederick Welt uses a compelling case study of a young woman with diabetes presenting with non-STEMI to demonstrate how advanced imaging reveals the full spectrum of coronary… View more
Author(s): Tiziana Claudia Aranzulla Added: 2 months ago
ESC Congress 2025 - Evolocumab on top of lipid lowering therapy(LLT) reduced adverse vascular events at 12 months.Dr Tiziana Claudia Aranzulla (Mauriziano Umberto Hospital, Turin, IT) joins us to discuss findings from CARUSO (NCT04730973). The trial aimed to assess the efficacy of evolocumab with traditional LLT compared to traditional LTT alone in the stabilisation and regression of carotid… View more
Added: 3 months ago Source:  Radcliffe Cardiology
AUTHOR: Sean DelaneyA greater number of traditional cardiovascular risk factors is strongly associated with increased coronary plaque vulnerability in patients with acute coronary syndrome (ACS), particularly in culprit lesions, according to a new analysis published in JACC.¹ The study provides a direct morphological link between the cumulative burden of risk factors and the high-risk plaque… View more
Author(s): Hector M Garcia-Garcia Added: 1 year ago
In this interview, Prof Garcia-Garcia explains the methodology and findings of the AI-based OCT analysis and how this could impact practice in the future. View more
Job title: Chairman of the lipid clinic
Prof Erik Stroes is Chairman of the lipid clinic at Amsterdam University Medical Center (UMC) in the Netherlands. Prof Stroes is a vascular internist with a longstanding track of research in the field of lipidology, inflammation and atherosclerosis. His current research foci encompass the use of CT-angiography as a guide to tailored treatment regimens, pathophysiology of Lp(a) in atherogenesis… View more
Author(s): Michelle O'Donoghue Added: 9 hours ago
AHA Scientific Sessions 2025 - Dr Michelle O'Donoghue (Brigham and Women's Hospital, US) joins us to discuss the evolving understanding of the causal relationship between elevated lipoprotein(a) and atherosclerotic cardiovascular disease, and what this means for risk stratification and management strategies in clinical practice.Dr O'Donoghue begins by highlighting the importance for clinicians to… View more
Job title: Clinical Professor and Director of Preventive Cardiology